While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other undervalued defensive Stocks for 2025. The consumer defensive sector covers products that everyone ...

The pipeline will run for about 213 kilometres to a $7.4 billion polyethylene plant where construction started last September ...

Teva Pharmaceutical Industries Ltd. ADR-0.95% $24.61B ...

The scrubbing of clinical trial-related pages is notable because of how it could affect the ways researchers both inside and ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK chief executive Andrew Witty told investors yesterday that Advair/Seretide sales are likely to continue to decline, although he insisted that the company is starting to see "some recovery in ...